The COVID-19 second wave: A perspective to be explored.
作者信息
Diaz Ricardo Sobhie, Vergara Tania Regina Constant
机构信息
Federal University of Sao Paulo, Paulista School of Medicine, Infectious Diseases Division, SP, Brazil.
Federal University of São Paulo, SP, Brazil.
出版信息
Braz J Infect Dis. 2021 Jan-Feb;25(1):101537. doi: 10.1016/j.bjid.2020.101537. Epub 2020 Dec 26.
Abstract
摘要
相似文献
1
The COVID-19 second wave: A perspective to be explored.新冠疫情第二波：一个有待探索的视角。
Braz J Infect Dis. 2021 Jan-Feb;25(1):101537. doi: 10.1016/j.bjid.2020.101537. Epub 2020 Dec 26.
2
Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based study.评估第二波 COVID-19 相对死亡率：一项前瞻性瑞士基于人群的研究。
BMJ Open. 2021 Oct 4;11(10):e051164. doi: 10.1136/bmjopen-2021-051164.
3
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间，一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异：canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
4
Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves.乳腺癌患者和幸存者在连续 SARS-CoV-2 感染波前后的身心健康。
Qual Life Res. 2023 Aug;32(8):2375-2390. doi: 10.1007/s11136-023-03400-6. Epub 2023 Apr 4.
5
SARS-CoV-2 clearance in term of Cycle Threshold (Ct) during first two waves of COVID-19 in Pakistan: a phenomenon of delayed viral clearance post-corticosteroid treatment.SARS-CoV-2 在巴基斯坦 COVID-19 前两波中的 Ct 值清除：皮质类固醇治疗后病毒清除延迟的现象。
Braz J Biol. 2024 Jul 8;84:e271452. doi: 10.1590/1519-6984.271452. eCollection 2024.
6
SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.意大利第一波和第二波 COVID-19 期间 SARS-CoV-2 感染发生率。
Environ Res. 2021 Jun;197:111097. doi: 10.1016/j.envres.2021.111097. Epub 2021 Apr 1.
7
A supply chain perspective on India's COVID-19 crisis: Lessons from the second wave and preparing for a potential third wave.从供应链视角看印度的新冠疫情危机：第二波疫情的教训及对潜在第三波疫情的应对准备
J Glob Health. 2021 Oct 23;11:03116. doi: 10.7189/jogh.11.03116. eCollection 2021.
8
9
SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.东亚和太平洋地区的 SARS-CoV-2 第二波监测：纵向趋势分析。
J Med Internet Res. 2021 Feb 1;23(2):e25454. doi: 10.2196/25454.
10
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.喀麦隆雅温得：第二波 COVID-19 期间社区 SARS-CoV-2 血清阳性率迅速上升。
Emerg Infect Dis. 2022 Jun;28(6):1233-1236. doi: 10.3201/eid2806.212580. Epub 2022 Apr 26.
引用本文的文献
1
Potential use of high-resolution melting analyses for SARS-CoV-2 genomic surveillance.高分辨率熔解曲线分析在 SARS-CoV-2 基因组监测中的潜在应用。
J Virol Methods. 2023 Jul;317:114742. doi: 10.1016/j.jviromet.2023.114742. Epub 2023 Apr 26.
2
Wastewater surveillance of SARS-CoV-2 genomic populations on a country-wide scale through targeted sequencing.通过靶向测序对全国范围内的 SARS-CoV-2 基因组种群进行污水监测。
PLoS One. 2023 Apr 21;18(4):e0284483. doi: 10.1371/journal.pone.0284483. eCollection 2023.
3
Clinical characteristics & severity profile of children with COVID-19 during the second wave pandemic: An experience from tertiary care hospital in Mumbai.新冠疫情第二波期间儿童 COVID-19 的临床特征和严重程度概况：孟买一家三级护理医院的经验。
Indian J Med Res. 2023 Jan;157(1):92-95. doi: 10.4103/ijmr.ijmr_813_22.
4
Comparing community mobility reduction between first and second COVID-19 waves.比较新冠疫情第一波和第二波期间社区流动性降低情况。
Transp Policy (Oxf). 2021 Oct;112:114-124. doi: 10.1016/j.tranpol.2021.08.004. Epub 2021 Aug 25.
5
The Unprecedented Role of 3D Printing Technology in Fighting the COVID-19 Pandemic: A Comprehensive Review.3D打印技术在抗击新冠疫情中的前所未有的作用：全面综述
Materials (Basel). 2022 Oct 1;15(19):6827. doi: 10.3390/ma15196827.
6
COVID-19 vaccination challenges: A mini-review.COVID-19 疫苗接种挑战：小型综述。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2066425. doi: 10.1080/21645515.2022.2066425. Epub 2022 May 5.
7
mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2.mRNA疫苗作为快速有效诱导宿主针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）产生免疫的一种方法。
SN Compr Clin Med. 2022;4(1):88. doi: 10.1007/s42399-022-01168-3. Epub 2022 Apr 1.
8
Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities.冠状病毒和碳纳米管：寻求免疫关系以发现免疫治疗可能性。
Int J Nanomedicine. 2022 Feb 21;17:751-781. doi: 10.2147/IJN.S341890. eCollection 2022.
9
A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic.当前新冠疫苗诱导宿主免疫的综述以及减轻疫情的简要非药物干预措施。
Bull Natl Res Cent. 2022;46(1):31. doi: 10.1186/s42269-022-00719-x. Epub 2022 Feb 16.
10
GASTROINTESTINAL COMPLICATIONS OF CORONAVIRUS DISEASE (COVID-19).冠状病毒病（COVID-19）的胃肠道并发症。
Arq Bras Cir Dig. 2022 Jan 5;34(3):e1620. doi: 10.1590/0102-672020210002e1620. eCollection 2022.
本文引用的文献
1
Genomic evidence for reinfection with SARS-CoV-2: a case study.基因组证据表明 SARS-CoV-2 再次感染：一项案例研究。
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
2
Antibody-dependent enhancement of coronavirus.抗体依赖性增强冠状病毒感染。
Int J Infect Dis. 2020 Nov;100:483-489. doi: 10.1016/j.ijid.2020.09.015. Epub 2020 Sep 11.
3
Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.临床灵敏度和对住院患者的 PCR 和血清学 COVID-19 诊断的解读。
FASEB J. 2020 Oct;34(10):13877-13884. doi: 10.1096/fj.202001700RR. Epub 2020 Aug 28.
4
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.2019 年冠状病毒病（COVID-19）通过全基因组测序确认为与严重急性呼吸综合征冠状病毒 2 株系不同的病毒再次感染。
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951. doi: 10.1093/cid/ciaa1275.
5
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
6
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
7
Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.使用免疫球蛋白G亲和力测定法区分西尼罗河病毒的初次感染和既往感染。
J Clin Microbiol. 2005 Dec;43(12):5873-5. doi: 10.1128/JCM.43.12.5873-5875.2005.
8
Antibody avidity maturation during severe acute respiratory syndrome-associated coronavirus infection.严重急性呼吸综合征相关冠状病毒感染期间抗体亲和力成熟
J Infect Dis. 2005 Jul 1;192(1):166-9. doi: 10.1086/430615. Epub 2005 May 25.
9
Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection.原发性EB病毒感染患者血清中的EB病毒（EBV）DNA
J Clin Microbiol. 2001 Nov;39(11):4152-4. doi: 10.1128/JCM.39.11.4152-4154;2001.
10
Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.
J Med Virol. 1991 Jan;33(1):6-9. doi: 10.1002/jmv.1890330103.
Zotero 插件